Copper Rock Capital Partners’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-365,817
Closed -$25.1M 75
2018
Q3
$25.1M Sell
365,817
-257,339
-41% -$16.6M 1.55% 22
2018
Q2
$35.7M Sell
623,156
-48,709
-7% -$2.57M 2.05% 4
2018
Q1
$31M Sell
671,865
-5,319
-0.8% -$253K 1.85% 22
2017
Q4
$31.6M Buy
677,184
+23,469
+4% +$1.08M 1.97% 23
2017
Q3
$29.8M Sell
653,715
-23,293
-3% -$994K 1.99% 21
2017
Q2
$26.8M Sell
677,008
-24,708
-4% -$934K 1.74% 25
2017
Q1
$26.8M Buy
+701,716
New +$27.3M 1.69% 33

Other funds holding AVNS

Copper Rock Capital Partners's AVNS Position: Q4 2018 in Review

Copper Rock Capital Partners sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 365,817 shares — an estimated $25.1M sold.

Copper Rock Capital Partners first reported a position in AVNS in Q1 2017 and held it in 7 quarters. The position peaked at $35.7M in Q2 2018. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Copper Rock Capital Partners reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Copper Rock Capital Partners sold 365,817 Avanos Medical shares in Q4 2018, an estimated $25.1M.
  • Copper Rock Capital Partners first reported a position in Avanos Medical in Q1 2017 and held it in 7 quarters.
  • Copper Rock Capital Partners's Avanos Medical position peaked at $35.7M in Q2 2018.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Copper Rock Capital Partners's 13F filing for Q4 2018, filed 9 Jan 2019.